Selumetinib is an MEK inhibitor. It’s used to treat a type of neurofibromatosis, specifically NF1, which includes symptoms like plexiform neurofibromas. It works by blocking the MEK signaling pathway that’s key in cell growth and development.
The suggested dose of Selumetinib is 25 mg per square meter of body surface area, taken twice a day on an empty stomach. You can get Selumetinib in two strengths — 10 mg and 25 mg capsules. Selumetinib comes in bottles with 60 capsules each.
